Research progress of azido-containing Pt(IV) antitumor compounds
Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2022-01, Vol.227, p.113927-113927, Article 113927 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 113927 |
---|---|
container_issue | |
container_start_page | 113927 |
container_title | European journal of medicinal chemistry |
container_volume | 227 |
creator | Mu, Meilin Zhan, Jiuyu Dai, Xiaohan Gao, Hongwei |
description | Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs.
[Display omitted]
•New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs. |
doi_str_mv | 10.1016/j.ejmech.2021.113927 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586504030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523421007765</els_id><sourcerecordid>2586504030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EglL4A4SyLIsUP2I73SAQ4lEJCYSAreXHpLhq4mInSPD1pEphyWo2586dOQidEDwlmIjz5RSWNdj3KcWUTAlhMyp30IhIUeaM8mIXjTClLOeUFQfoMKUlxpgLjPfRASvEjEvJR-jyGRLoaN-zdQyLCCllocr0t3cht6FptW98s8ie2sn87SzTTevbrg4xs6Feh65x6QjtVXqV4Hg7x-j19ubl-j5_eLybX1895JYJ2uakAiM5N8RQUZQFA2wqq-XMlDMqJJfOMs2LSpbM6IoTI4hx2BhunATiBGdjNBn29nd-dJBaVftkYbXSDYQuKcpLwXGBGe7RYkBtDClFqNQ6-lrHL0Ww2rhTSzW4Uxt3anDXx063DZ2pwf2FfmX1wMUAQP_np4eokvXQWHA-gm2VC_7_hh_WOoFP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586504030</pqid></control><display><type>article</type><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</creator><creatorcontrib>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</creatorcontrib><description>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs.
[Display omitted]
•New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2021.113927</identifier><identifier>PMID: 34695775</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Anticancer ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Azides - chemistry ; Azides - pharmacology ; Cell Proliferation - drug effects ; Diazido ; Drug Development ; Humans ; Neoplasms - drug therapy ; Neoplasms - pathology ; Organoplatinum Compounds - chemistry ; Organoplatinum Compounds - pharmacology ; Photoactivation ; Prodrugs ; Pt(IV)</subject><ispartof>European journal of medicinal chemistry, 2022-01, Vol.227, p.113927-113927, Article 113927</ispartof><rights>2021 Elsevier Masson SAS</rights><rights>Copyright © 2021 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</citedby><cites>FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0223523421007765$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34695775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mu, Meilin</creatorcontrib><creatorcontrib>Zhan, Jiuyu</creatorcontrib><creatorcontrib>Dai, Xiaohan</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs.
[Display omitted]
•New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</description><subject>Anticancer</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Azides - chemistry</subject><subject>Azides - pharmacology</subject><subject>Cell Proliferation - drug effects</subject><subject>Diazido</subject><subject>Drug Development</subject><subject>Humans</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - pathology</subject><subject>Organoplatinum Compounds - chemistry</subject><subject>Organoplatinum Compounds - pharmacology</subject><subject>Photoactivation</subject><subject>Prodrugs</subject><subject>Pt(IV)</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EglL4A4SyLIsUP2I73SAQ4lEJCYSAreXHpLhq4mInSPD1pEphyWo2586dOQidEDwlmIjz5RSWNdj3KcWUTAlhMyp30IhIUeaM8mIXjTClLOeUFQfoMKUlxpgLjPfRASvEjEvJR-jyGRLoaN-zdQyLCCllocr0t3cht6FptW98s8ie2sn87SzTTevbrg4xs6Feh65x6QjtVXqV4Hg7x-j19ubl-j5_eLybX1895JYJ2uakAiM5N8RQUZQFA2wqq-XMlDMqJJfOMs2LSpbM6IoTI4hx2BhunATiBGdjNBn29nd-dJBaVftkYbXSDYQuKcpLwXGBGe7RYkBtDClFqNQ6-lrHL0Ww2rhTSzW4Uxt3anDXx063DZ2pwf2FfmX1wMUAQP_np4eokvXQWHA-gm2VC_7_hh_WOoFP</recordid><startdate>20220105</startdate><enddate>20220105</enddate><creator>Mu, Meilin</creator><creator>Zhan, Jiuyu</creator><creator>Dai, Xiaohan</creator><creator>Gao, Hongwei</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220105</creationdate><title>Research progress of azido-containing Pt(IV) antitumor compounds</title><author>Mu, Meilin ; Zhan, Jiuyu ; Dai, Xiaohan ; Gao, Hongwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-1feb755b1b264843e0bfca79b8926757dc3a54f783baf51b61bd0bb5bd7e1d653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticancer</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Azides - chemistry</topic><topic>Azides - pharmacology</topic><topic>Cell Proliferation - drug effects</topic><topic>Diazido</topic><topic>Drug Development</topic><topic>Humans</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - pathology</topic><topic>Organoplatinum Compounds - chemistry</topic><topic>Organoplatinum Compounds - pharmacology</topic><topic>Photoactivation</topic><topic>Prodrugs</topic><topic>Pt(IV)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mu, Meilin</creatorcontrib><creatorcontrib>Zhan, Jiuyu</creatorcontrib><creatorcontrib>Dai, Xiaohan</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mu, Meilin</au><au>Zhan, Jiuyu</au><au>Dai, Xiaohan</au><au>Gao, Hongwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research progress of azido-containing Pt(IV) antitumor compounds</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2022-01-05</date><risdate>2022</risdate><volume>227</volume><spage>113927</spage><epage>113927</epage><pages>113927-113927</pages><artnum>113927</artnum><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>Cancer is a long-known incurable disease, and the medical use of cisplatin has been a significant discovery. However, the side-effects of cisplatin necessitate the development of new and improved drug. Therefore, in this study, we focused on the photoactivatable Pt(IV) compounds Pt[(X1)(X2)(Y1)(Y2)(N3)2], which have a completely novel mechanism of action. Pt(IV) can efficiently overcome the side-effects of cisplatin and other drugs. Here, we have demonstrated, summarized and discussed the effects and mechanism of these compounds. Compared to the relevant articles in the literature, we have provided a more detailed introduction and a made comprehensive classification of these compounds. We believe that our results can effectively provide a reference for the development of these drugs.
[Display omitted]
•New drug development is necessary because of the problems of classic platinum drugs.•Azido-containing platinum(IV) compounds have new mechanisms and excellent cytotoxicity.•The reaction and toxicity information of the new azido-containing platinum(IV) compounds is collected.•Azide-containing platinum (IV) compounds will play an important role in the development of new drugs.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>34695775</pmid><doi>10.1016/j.ejmech.2021.113927</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2022-01, Vol.227, p.113927-113927, Article 113927 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_2586504030 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Anticancer Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Azides - chemistry Azides - pharmacology Cell Proliferation - drug effects Diazido Drug Development Humans Neoplasms - drug therapy Neoplasms - pathology Organoplatinum Compounds - chemistry Organoplatinum Compounds - pharmacology Photoactivation Prodrugs Pt(IV) |
title | Research progress of azido-containing Pt(IV) antitumor compounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A46%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20progress%20of%20azido-containing%20Pt(IV)%20antitumor%20compounds&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Mu,%20Meilin&rft.date=2022-01-05&rft.volume=227&rft.spage=113927&rft.epage=113927&rft.pages=113927-113927&rft.artnum=113927&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2021.113927&rft_dat=%3Cproquest_cross%3E2586504030%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586504030&rft_id=info:pmid/34695775&rft_els_id=S0223523421007765&rfr_iscdi=true |